Alzheimer's disease could be prevented by antiviral drug already on market
NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved to treat HIV infection, but scientists from UVA Health at the University of Virginia found that patients taking them were less likely to develop the common form of dementia.
There was a roughly 10% annual reduction in the risk of developing Alzheimer's disease in people taking NRTIs for every year of use of these drugs, according to lead study author Dr. Jayakrishna Ambati, M.D., professor of ophthalmology at UVA, who spoke to Fox News Digital about the finding.
Alzheimer's Brain Treatment Shows Promising Results In New Study
After coming across another mechanism that could potentially prevent Alzheimer's, the researchers analyzed 24 years of health insurance data, including 270,000 patients.
The Alzheimer's risk reduction among patients taking NRTIs was "significant and substantial," the researchers wrote in the findings, which were published in the journal Alzheimer's & Dementia.
Read On The Fox News App
Now, the UVA team is calling for clinical trials of NRTIs to gauge their use for treating Alzheimer's.
Approximately 10 million people worldwide are diagnosed with the common dementia each year.
Alzheimer's Rates Have Reached Staggering Number As Experts Call For Change
"This level of protection could translate into 60,000 fewer cases of Alzheimer's disease every year in our country, and up to one million fewer cases every year around the world," Ambati told Fox News Digital.
In addition to keeping the HIV virus from replicating, NRTIs also prevent the activation of inflammasomes, proteins that are involved in the development of Alzheimer's.
"We had previously shown that NRTIs blocked the inflammasome, so it wasn't altogether surprising that people taking NRTIs might be protecting against this disease," Ambati noted.
"However, the degree of protection against Alzheimer's was quite surprising."
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, was not involved in the study but commented on the findings.
"Inflammasomes are intracellular protein complexes that trigger the release of inflammatory cytokines," he told Fox News Digital. "HIV uses these inflammasomes to fight the immune system."
"These chemicals are likely responsible for making Alzheimer's worse, or for accelerating the process of cognitive decline based on neuro-inflammation."
Rebecca Edelmeyer, Ph.D., vice president of Scientific Engagement at the Alzheimer's Association in Chicago, also reviewed the study's findings, which she called "interesting."
'I'm A Neurologist — Here's Why Dementia Is Rising And How To Reduce Your Risk'
"Further research and specifically designed clinical trials are needed to fully understand the potential future use of NRTIs to reduce the risk of Alzheimer's, but the study highlights the potential role drug repurposing can play in advancing new Alzheimer's treatments," she told Fox News Digital.
Repurposing existing drugs can offer a "promising pathway," according to Edelmayer. As existing drugs' safety and side effects are often already known, the studies can be quicker and less expensive than with new treatments, she added.
The research team acknowledged some limitations of the study.
"Like all retrospective health insurance database studies, the findings of our study are an association between this class of drugs and the development of Alzheimer's disease," Ambati told Fox News Digital.
"They don't necessarily provide a cause and effect — however, the fact that we found this link in multiple databases increases confidence in this result."
Siegel agreed that the new study is observational, but noted that it takes place over many years.
"It also shows that only this particular HIV drug — inflammasome — dramatically decreases the risk of Alzheimer's, not the other HIV drugs, including protease inhibitors," the doctor said.
"I think this is convincing preliminary evidence that warrants further study," Siegel added. "It is very possible that this drug may be useful in Alzheimer's prevention, given the increasing evidence implicating immune dysregulation and inflammation as causes of AD."
Looking ahead, the researchers have developed a new drug called K9. Like NRTIs, the novel medication blocks inflammasomes, but is "safer and more effective," according to Ambati.
Click Here To Sign Up For Our Health Newsletter
"The fact that the new drug reversed memory loss and improved spatial learning in mice further increases confidence in our findings," he told Fox News Digital.
The UVA team now plans to test K9 in clinical trials for Azheimer's.
Ambati noted that people should not take NRTIs for Alzheimer's prevention unless they are in the context of a clinical trial.
"If interested, they should be on the lookout for such trials for themselves or loved ones who may be affected," he advised.
For more Health articles, visit www.foxnews.com/health
Nearly seven million people in the U.S. are currently living with Alzheimer's, and the number is expected to reach 13 million by 2050, according to the Alzheimer's Association.
The UVA study was funded in part by the UVA Strategic Investment Fund and the National Institutes of Health.Original article source: Alzheimer's disease could be prevented by antiviral drug already on market
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
an hour ago
- Washington Post
Every VA medical center has severe staffing shortages, audit finds
The independent watchdog for the Department of Veterans Affairs said the agency's health system is facing a severe staffing shortage of clinical and nonclinical workers that has worsened since last year — at the same time the agency has shed tens of thousands of workers and recruited fewer medical workers. The inspector general's office released its annual report Tuesday, revealing the extent of staffing shortages that have plagued the agency for years and have worsened this year. All of the Veterans Health Administration's 139 medical centers reported lacking workers, and reports of severe shortages increased 50 percent from the previous fiscal year.
News24
an hour ago
- News24
Gambia baby death heightens alarm over female genital mutilation
A baby's death in The Gambia linked to female genital mutilation (FGM) has sparked outrage and calls for justice. FGM, illegal but prevalent in The Gambia, was linked to severe health risks and over 44 000 global deaths annually. The Gambia's Supreme Court is reviewing the 2015 FGM ban amidst pressure from religious traditionalists to overturn it. Rights activists in The Gambia are calling for justice after a one-month-old baby's death was linked to female genital mutilation, a widely practised but illegal procedure up for review before the country's Supreme Court. The Gambia has one of the highest rates of FGM in the world, with 73% of women and girls aged 15 to 49 having undergone the procedure, according to 2024 figures from UNICEF. The baby girl was pronounced dead upon arrival at a hospital in the capital, Banjul, after being 'allegedly subjected to circumcision' and developing severe bleeding, The Gambia Police Force said in a statement on Sunday. The death has sparked outrage among women's rights defenders working to combat the deeply rooted cultural and religious practice that they say is a harmful violation against women and girls. 'FGM is not a cultural tradition to be defended - it is a form of gender-based violence that can kill,' Santana Simiyu, a human rights lawyer with rights group Equality Now, said in a statement sent to AFP Tuesday. Police said two women allegedly involved in the case are in custody as an investigation is carried out in the western town of Wellingara, where the incident occurred. READ | Body parts found: Traditional healer linked to Gontse Makhubela's murder Researchers at Britain's University of Birmingham estimated in a study published in 2023 that approximately 44 320 girls and young women die each year due to FGM in the countries where it is practised. Former Gambian dictator Yahya Jammeh, now in exile, outlawed FGM in 2015, branding it outdated and not a requirement of Islam. Later that year, Parliament adopted the first law specifically banning the practice, which is now punishable by up to three years in prison but is rarely enforced. In July 2024, lawmakers revisited the matter, upholding the 2015 law despite pressure from religious traditionalists. But the ban was immediately challenged before the Gambian Supreme Court, where the petition remains pending. Simiyu said: If the Gambia's Supreme Court rules that the country's law prohibiting FGM is unconstitutional, it would have a hugely detrimental impact on the well-being of women and girls, leaving them without legal protections. FGM involves the partial or total removal of the female external genitalia or other injuries to the female genital organs. It can lead to serious health problems, including infections, bleeding, infertility and complications in childbirth.
WebMD
2 hours ago
- WebMD
Breakthroughs in HIV
It's been over 40 years since the emergence of HIV. It's killed hundreds of thousands of Americans, and millions of people globally. Those numbers would be even higher without medical breakthroughs. Let's talk about some of them. In 1996, Highly Active Antiretroviral Therapy (HAART) was developed. It suppresses the virus from replicating and attacking your immune system, which lowers your viral load and increases the CD4 (white blood cells that fight infections for your immune system). That reduces your risk of opportunistic infections and extends your life expectancy. The decrease in viral load makes HIV less transmissible and helps reconstitute your immune system, but it took a while before it was known by how much This was a major breakthrough in HIV treatment and prevention. But it was hardly the first. Perhaps the first big break came in 1983, when scientists isolated the virus that pinpointed the cause of AIDS. This revolutionized the understanding of AIDS — where it was, how it works, and how to combat it. Then in 1985, the first HIV blood test was licensed. This was a breakthrough of sorts, because it allowed the virus to be detected before it was too late. But there was still no treatment. That came in 1987 when AZT was developed. AZT was the first antiretroviral treatment for HIV-AIDS. It helped and prevented mother-to-child transmission of the virus. But it had serious side effects. I've heard horrible stories from AZT survivors, but it was all that was available at the 1996, when HAART changed everything. By 1997, it was the standard of care for new HIV cases. In 2012, it was discovered that providing HIV medication to HIV-negative people at high risk for the virus could prevent transmission, with an incredible success rate. This is called pre-exposure prophylaxis or PrEP. It was meant to be another amazing breakthrough in science. For the first time, there was a proven method of preventing HIV transmission. The implications included ending transmission of HIV, and ending the HIV-AIDS epidemic. But PrEP hasn't been widely accepted by the public, mostly due to stigma associated with HIV and LGBTQ people. So we're yet to achieve those goals. The year 2016 changed my life more than any other. I was at a conference in Florida where Bruce Richman spoke about U=U. It played a huge role in my decision to become an HIV advocate. I've been an ambassador for U=U ever since. What is U=U? Undetectable equals Untransmittable means that when you take HIV medication as prescribed, you can achieve an undetectable viral load. This means there's not enough virus in your blood to be counted. What happens to the virus? Small amounts of it can survive but remain harmlessly dormant in your body, in small amounts known as reservoirs. The virus can't be transmitted sexually or mother to child. People who live with HIV can safely have children with no risk of transmission to their partner or baby. This revelation was monumental and it's changed lives. It was a breakthrough in understanding. In 2021, there came the first long-acting injectable. It was a breakthrough for those who struggled with pill fatigue or forgetfulness. Pill fatigue is a common problem, especially because there's also stigma associated with simply taking meds for HIV. I remember learning about injectable HIV medication at a conference called CROI (Conference on Retroviruses and Opportunistic Infections). It's a scientific event that attracts leading experts who discuss research and findings for collective understanding. I've attended the conference twice as a community liaison and learned so much about HIV research and the experts doing it. I learned about the potential for longer acting treatments, and about research exploring different methods of delivery, from injectable treatments to the possibility of implants. I can tell you that even a few years ago, research for a cure of HIV-AIDS was getting really exciting. I truly believe we're close to finding a cure. Now is not the time to kill funding dedicated to this research. I've talked about a lot of breakthroughs in HIV. This year, that list of breakthroughs adds another big advancement. In 2025 the FDA approved a drug that can be injected twice yearly, once every 6 months. It can also be used as PrEP, which has also been approved. That's incredible! You don't have to remember to take meds every day, carry meds with you, or be seen taking them. I hold on to hope that one day one of these breakthroughs will change public perception of HIV. There's no reason to fear this virus as long as you have access to the medicine. The stigma of HIV is antiquated. It's based on a mysterious disease that was a certain death sentence and only affects gay men But none of this is true anymore. HIV is no longer the deadly disease it once was. With incredible advancements, there's no excuse for fear or stigma to exist. HIV today is nothing more than a chronic condition that's easily managed, and only getting better with time. I believe we're close to a cure. I just learned that researchers have found a way to awaken dormant HIV cells. I find that extremely exciting and wonder if it could lead to a cure. If dormant cells can be awakened, then targeted and killed, that could be a cure. It's so exciting that we're getting closer, so it's no time for defunding HIV research and prevention efforts.
